Kura Oncology (KURA) Tops Q2 EPS by 4c

Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.59), $0.04 better than the analyst estimate of ($0.63).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Rocket Lab launches U.S. Space Force mission in record 16 hours
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink